These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3879119)

  • 1. Prenatal therapy in congenital adrenal hyperplasia. Attempted prevention of abnormal external genital masculinization by pharmacologic suppression of the fetal adrenal gland in utero.
    Chrousos GP; Evans MI; Loriaux DL; McCluskey J; Fletcher JC; Schulman JD
    Ann N Y Acad Sci; 1985; 458():156-64. PubMed ID: 3879119
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY; Pollack MS; Marshall RN; Immken L
    N Engl J Med; 1990 Jan; 322(2):111-5. PubMed ID: 2403652
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
    David M; Forest MG
    J Pediatr; 1984 Nov; 105(5):799-803. PubMed ID: 6334149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia.
    Evans MI; Chrousos GP; Mann DW; Larsen JW; Green I; McCluskey J; Loriaux DL; Fletcher JC; Koons G; Overpeck J
    JAMA; 1985 Feb; 253(7):1015-20. PubMed ID: 3968825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Migeon CJ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):836-7. PubMed ID: 2318944
    [No Abstract]   [Full Text] [Related]  

  • 6. An update of congenital adrenal hyperplasia.
    New MI; Dupont B; Pang S; Pollack M; Levine LS
    Recent Prog Horm Res; 1981; 37():105-81. PubMed ID: 7025132
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal diagnosis and management of congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Passarge E
    Indian J Pediatr; 1988; 55(4):472-5. PubMed ID: 3262582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adrenal hyperplasia as a result of 21-hydroxylase deficiency: prenatal diagnosis and treatment. Neonatal diagnosis].
    Lambotte C
    Rev Med Liege; 1986 Jan; 41(2):37-44. PubMed ID: 3006204
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful antenatal treatment of an affected congenital adrenal hyperplasia pregnancy using linkage analysis.
    Day DJ; Fitness JE; Milsom S
    Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):369-71. PubMed ID: 15282019
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal treatment of congenital adrenal hyperplasia.
    Lancet; 1990 Mar; 335(8688):510-1. PubMed ID: 1968533
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic counseling and prenatal diagnosis of adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Couillin P
    Presse Med; 1984 Apr; 13(17):1087-90. PubMed ID: 6232534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial congenital adrenal hyperplasia caused by 11 beta-hydroxylase. Failure of prevention of sexual ambiguity and prenatal diagnosis].
    Bouchard M; Forest MG; David M; Dechaud H; Juif JG
    Pediatrie; 1989; 44(8):637-40. PubMed ID: 2622705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linkage between congenital adrenal hyperplasia with 21-hydroxylase deficiency and HLA histocompatibility groups].
    Cruz-Marin F; Raffoux C; Gilgenkrantz S; Janot C; Streiff F; Pierson M
    J Genet Hum; 1981 Mar; 29(1):103-13. PubMed ID: 6977617
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenatal diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency by steroid analysis in the amniotic fluid of mid-pregnancy: comparison with HLA typing in 17 pregnancies at risk for CAH.
    Forest MG; Bétuel H; Couillin P; Boué A
    Prenat Diagn; 1981 Jul; 1(3):197-207. PubMed ID: 6981108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Pang S; Pollack MS; Loo M; Green O; Nussbaum R; Clayton G; Dupont B; New MI
    Ann N Y Acad Sci; 1985; 458():111-29. PubMed ID: 3879117
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal diagnosis of congenital adrenal hyperplasia (21-OH deficiency type) by HLA typing.
    Couillin P; Boue J; Nicolas H; Cheruy C; Boue A
    Prenat Diagn; 1981 Jan; 1(1):25-33. PubMed ID: 6955777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in prenatal diagnosis of 21-hydroxylase deficiency by amniotic fluid steroid analysis? A six years experience in 102 pregnancies at risk.
    Forest MG
    Ann N Y Acad Sci; 1985; 458():130-47. PubMed ID: 3879118
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of gamma interferon to increase HLA antigen expression on cultured amniotic cells used for the prenatal diagnosis of 21-hydroxylase deficiency.
    Maurer DH; Pollack MS
    Ann N Y Acad Sci; 1985; 458():148-55. PubMed ID: 3937472
    [No Abstract]   [Full Text] [Related]  

  • 19. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S; Clark AT; Freeman LC; Dolan LM; Immken L; Mueller OT; Stiff D; Shulman DI
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect on the fetal pituitary-adrenal axis of dexamethasone administration early in the second trimester of pregnancy.
    Mesogitis S; Daskalakis G; Papapetrou P; Mavroudis K; Papandroulaki F; Papantoniou N; Antsaklis A
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):109-12. PubMed ID: 20528220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.